High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector

Journal of General Virology

Volumn 88, Issue 11, 2007, Pages 2915-2924

  Vogels, Ronald ^a   Zuijdgeest, David ^a   van Meerendonk, Michelle ^a   Companjen, Arjen ^a   Gillissen, Gert ^a   Sijtsma, Jeroen ^a   Melis, Irene ^a   Holterman, Lennart ^a   Radosevic, Katarina ^a   Goudsmit, Jaap ^a,b   Havenga, Menzo J E ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIGEN; CIRCUMSPOROZOITE PROTEIN; DNA; DRUG CARRIER; GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; ADENOVIRUS 35; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG DESIGN; EXPRESSION VECTOR; GENE CASSETTE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; MALARIA; MOLECULAR STABILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; TUBERCULOSIS; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; GENE EXPRESSION; GENETIC VECTORS; HIV ENVELOPE PROTEIN GP120; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; PROMOTER REGIONS (GENETICS); PROTOZOAN PROTEINS; RNA 3' POLYADENYLATION SIGNALS; SPLEEN; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRUS REPLICATION;

ADENOVIRIDAE; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; PLASMODIUM FALCIPARUM;

EID: 36249019262     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83119-0     Document Type: Article

References (26)

1. Basler, C. F. & Horwitz, M. S. (1996). Subgroup B adenovirus type 35 early region 3 mRNAs differ from those of the subgroup C adenoviruses. Virology 215, 165-177.
2. Bauzon, M., Castro, D., Karr, M., Hawkins, L. K. & Hermiston, T. W. (2003). Multigene expression from a replicating adenovirus using native viral promoters. Mol Ther 7, 526-534.
3. Belousova, N., Harris, R., Zinn, K., Rhodes-Selser, M. A., Kotov, A., Kotova, O., Wang, M., Aurigemma, R., Zhu, Z. B. & other authors 2006). Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassette. Mol Pharmacol 70, 1488-1493.
4. Bennekov, T., Dietrich, J., Rosenkrands, I., Stryhn, A., Doherty, T. M. & Andersen, P. (2006). Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur J Immunol 36, 3346-3355.
5. Berenjian, S. & Akusjarvi, G. (2006). Binary AdEasy vector systems designed for Tet-ON or Tet-OFF regulated control of transgene expression. Virus Res 115, 16-23.
6. Bett, A. J., Haddara, W., Prevec, L. & Graham, F. L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 91, 8802-8806.
7. Bramson, J., Hitt, M., Gallichan, W. S., Rosenthal, K. L., Gauldie, J. & Graham, F. L. (1996). Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Ther 7, 333-342.
8. Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L. & other authors (2006). Phase 1 safety and immunogenicity evaluation of a multiclade HIV- 1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J Infect Dis 194, 1638-1649.
9. Danthinne, X. & Werth, E. (2000). New tools for the generation of E1- and/or E3-substituted adenoviral vectors. Gene Ther 7, 80-87.
10. Fallaux, F. J., Bout, A., van der Velde, I., van den Wollenberg, D. J., Hehir, K. M., Keegan, J., Auger, C., Cramer, S. J., van Ormondt H. & other authors (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9, 1909-1917.
11. Ghosh-Choudhury, G., Haj-Ahmad, Y., Brinkley, P., Rudy, J. & Graham, F. L. (1986). Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene 50, 161-171.
12. Gonzalez- Nicolini, V. & Fussenegger, M. (2005). A novel binary adenovirus-based dual-regulated expression system for independent transcription control of two different transgenes. J Gene Med 7, 1573-1585.
13. Havenga, M., Vogels, R., Zuijdgeest, D., Radosevic, K., Mueller, S., Sieuwerts, M., Weichold, F., Damen, I., Kaspers, J. & other authors (2006). Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. J Gen Virol 87, 2135-2143.
14. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W. & Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95, 2509-2514.
15. Huang, Y., Kong, W. P. & Nabel, G. J. (2001). Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol 75, 4947-4951.
16. + lymphocyte depletion in rhesus monkeys. J Virol 71, 4218-4225.
17. Lee, K. H., Kim, H. K., Paik, J. Y., Matsui, T., Choe, Y. S., Choi, Y. & Kim, B. T. (2005). Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector. J Nucl Med 46, 652-657.
18. + T-lymphocyte epitope immunodominance hierarchies. J Virol 80, 11991-11997.
19. Murakami, P., Pungor, E., Files, J., Do, L., Van Rijnsoever, R., Vogels, R., Bout A. & McCaman, M. (2002). A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles. Hum Gene Ther 13, 909-920.
20. Nanda, D., Vogels, R., Havenga, M., Avezaat, C. J., Bout, A. & Smitt, P. S. (2001). Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Cancer Res 61, 8743-8750.
21. Putzer, B. M., Hitt, M., Muller, W. J., Emtage, P., Gauldie, J. & Graham, F. L. (1997). Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc Natl Acad Sci U S A 94, 10889-10894.
22. + T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon. J Virol 76, 4251-4259.
23. Steinwaerder, D. S., Carlson, C. A. & Lieber, A. (1999). Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats. J Virol 73, 9303-9313.
24. Toapanta, F. R., Craigo, J. K., Montelaro, R. C. & Ross, T. M. (2007). Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Curr HIV Res 5, 199-209.
25. Vellinga, J., Van der Heildt S. & Hoeben, R. C. (2005). The adenovirus capsid: major progress in minor proteins. J Gen Virol 86, 1581-1588.
26. Yewdell, J. W. & Bennink, J. R. (1999). Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17, 51-88.